Advances In Benzothiazole Scaffold: A Review of Synthesis and Medicinal Significance

1 Available online at www.derpharmachemica.com ISSN 0975-413X CODEN (USA): PCHHAX Der Pharma Chemica, 2023, 15(5): 1-28 (http://www.derpharmachemica.com/archive.html) Advances In Benzothiazole Scaffold: A Review of Synthesis and Medicinal Significance Vivian Ifeoma Okonkwo1, Chinedu Emmanuel Nnadi1 and Ebuka Leonard Onyeyilim2,3* 1Department of Science Laboratory Technology University of Nigeria, Nsukka 2Department of Pure and Industrial Chemistry University of Nigeria, Nsukka 3Department of Chemistry, University of Iowa,USA *Corresponding author: Ebuka Leonard Onyeyilim, Department of Pure and Industrial Chemistry University of Nigeria, Nsukka and Department of Chemistry, University of Iowa, E-mail: [email protected] Received: 23-June-2023, Manuscript no: dpc-23-103594, Editor assigned: 26-June-2023, PreQC No: dpc-23-103594, Reviewed: 10-July-2023, QC No: dpc-23-103594, Revised: 14-July-2023, Manuscript No: dpc-23-103594, Published: 31-August-2023, DOI: 10.4172/0975-413X.15.5.1-28 ABSTRACT A large number of bioactive heterocycles have been synthesized and reported to exhibit a wide range of biological properties including anticancer, antimicrobial, antidiabetic, anticonvulsant, anti-inflammatory, antiviral, antitubercular activities. In recent years there have been some interesting developments in the biological activities of benzothiazole derivatives. These compounds have special significance in the field of medicinal chemistry due to their remarkable pharmacological potentialities. The heterocycles bearing benzothiazole nucleus were synthesized using One-pot synthetic approach, which involved One-pot condensation of 2-aminothiophenol with different aromatic aldehydes, alcohols and carboxylic acids. Microwave promoted Suzuki-Miyaura coupling approach and Catalytic synthetic methodology were also employed in this synthesis. This review does not only disclose facile synthetic methodologies to benzothiazoles nucleus and their Schiff bases but also their medicinal significance and structure activity relationship can be seen in Graph 1. 2 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Graph 1 : Graphical abstract of Synthesis and medicinal significance of benzothiazole derivatives Keywords: Benzothiazoles; Schiff bases; Synthesis; Structure Activity Relationship; Antimicrobial; Anti-inflammatory; Anti tubercular; Anticancer; Anti diabetic; Anti-ulcer; Anti-viral; Anti convulsant INTRODUCTION Benzothiazole are classes of organic compound characterized with the basic skeleton (C7H5NS). They belong to the family of bicyclic heterocyclic compounds having benzene nucleus fused with five-membered ring comprising nitrogen and sulfur atoms. 2-substituted benzothiazole has emerge in its usage as a core structure in the diversified therapeutically applications. The study of structure-activity relationship interestingly reveals that change of the structure of substituent group at C-2 position commonly results to change of its bioactivity. Benzothiazole and their Schiff bases are very important biological compound with reference to various biological activities such as antimicrobial [1-5], anticancer [6-9],anti-helmintic [10],anti-diabetic activities [11], anti-tubercular [12,13], anti-malaria [14], anticonvulsant [15-16], analgesic [17] ,anti-inflammatory [18], antitumor [19] anti-viral [20,21], anti-oxidant [22], anti-glutamate and anti-parkinsonism [23], muscle relaxant activities [24], neuroprotective [25], inhibitors of several enzymes [26]. Marine and terrestrial natural compounds where the original sources of benzothiazole ring system, which was widely used as vulcanization accelerators, antioxidants, plant growth regulators, anti-inflammatory agents, enzyme inhibitors, imaging reagents, fluorescence materials and electroluminescent device as a result of its highly pharmaceutical and biological activity [27-30]. They are widely found in bioorganic and medicinal chemistry with application in drug discovery [31]. Thus, Benzothiazole is a privileged bicyclic ring system with multiple applications. In the 1950s, a number of 2amino benzothiazole derivatives were report as central muscle relaxants. Since then, medicinal chemists have not taken active interest in this chemical family. Biologist’s attention was drawn to this series when the pharmacological profile of riluzole was discovered [32]. Riluzole (6trifluoromethoxy-2-benzothiazolamine, PK-26124, RP25279, Rilutek) was found to interfere with glutamate neurotransmission in biochemical, electrophysiological, and behavioral experiments. After that benzothiazole derivatives have been studied extensively and found to have diverse chemical reactivity and broad spectrum of biological activity. Various benzothiazoles such as 2-aryl benzothiazole received much attention due to unique structure and its uses as radioactive amyloid imagining agents [33] and anticancer agents [34]. In last few years, it was reported that benzothiazole, its bioisosters and derivatives had antimicrobial activities against Gram-negative, Gram‐ positive bacteria (e.g. Enterobacter, Pseudomonas aeruginosa, E. coli, and Staphylococcus epidermidis etc.) and the yeast (e.g., Candida albicans). Benzothiazole nucleus as seen in Figure 1 has wide applications in dyes such as thioflavin [35]. According literature, several works on benzothiazole derivatives have been reported, briefly describing the synthetic strategies and their biological activities of [36-39]. 3 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Figure 1. Basic Structure of Benzothiazole The basic structure of benzothiazole consist of benzene ring fused with 4, 5 position of thiazole. The IR spectrum of the compound showed absorption peak at 3344cm-1, 3025cm-1, 1630cm-1, 690cm-1 due to stretching of N-H, C-H, C=N, C-S [40]. The Structure Activity Relationship of the benzothiazole nucleus is summarized in Figure 2 below. Figure 2. Structure Activity Relationship of Benzothiazole nucleus Compounds (2 and 3) were found to exhibit bactericidal activity and anti-inflammatory [41]. Introduction of methoxy group (-OCH3) at position 4 of 2-mercapto benzothiazole (4) was found to exhibit antibacterial activity [3]. The presence of electron withdraw group (-Cl) at position 4 of 2mercaptobenzothiazole (5) increases antifungal activity [3]. Chloro substituted amino benzothiazole (6) is found to encourage sensitivity to cancer line compare to flouro substituted benzothiazole [42]. Heterocyclic rings, 1-acetyl-pyrazoline and thiazole do not support eminently for anticancer activity but is use as fungicide and bactericide. Synthetic Approaches to Benzothiazole Derivatives (2) To date, different methods have been developed for the preparation of benzothiazole derivatives, some of which includes: Synthesis of Benzothiazole from Aniline (2.1) Murthi and Pathak (2008) reported the Synthesis of substituted 2-mercapto benzothiazole derivatives (9) with different substituents at 4, 5, and 6position in the benzothiazole ring system and this is carried out in two steps; step 1 involved the conversion of substituted anilines (7) to its hydrochloride salts. Subsequently the Aniline hydrochloride salt (8) was then cyclized in step 2 to substituted 2-mercaptobenzothiazoles by reacting with carbon disulphide in presence of sulfur in an alkaline medium Scheme 1 [3]. Scheme 1: Synthesis of 2-mercapto benzothiazole derivatives Synthesis from Aniline and Potassium Thiocyanate (2.1.1) Trapani, et al., (1992) reported the synthesis of substituted 2-ethoxycarbonyl-imidazo benzothiazole derivatives (13), this was carried out by reacting different substituted aniline (10) and potassium thiocyanate (11) in presence of bromine in acetic acid to give the intermediate 2-amino substituted benzothiazole (12). Stoichiometric amount of (12) and ethyl 2-bromo-2-oxoacetate in dimethyl formamide were reacted to afford the targeted derivatives (13) Scheme 2 [43]. 4 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Scheme 2: Synthesis of 2-ethoxycarbonyl-imidazole benzothiazole derivatives Synthesis of Benzothiazoles from 2-Aminothiophenol (2.2) Synthesis of benzothiazole from 2-aminothiophenol and different aromatic aldehydes (2.2.1) Khan, et al., 2011 reported an efficient method for the synthesis of 2-substituted benzothiazoles (16) of which high yield of 2-substituted benzothiazole (16) was obtained by condensation of 2-aminothiophenol (14) with different substituted aromatic aldehydes (15) in N,Ndimethylformamide (DMF) and sodium metabisulfite (Na2S2O5) under reflux conditions of 2 hours Scheme 3 [44]. Scheme 3: Synthesis of 2-substituted benzothiazole from 2-aminithiophenol and different aromatic aldehydes Yamazaki, et al., (2015) employed similar method for the synthesis of 4, 6-bis (4-[benzo[d]thiazole-2-yl) phenoxy)-N-N-diethyl-1,3,5-triazin-2amine (18). This was achieved by initially treating aromatic aldehyde, ((diethylamino)phenyl)-1,3,5-triazine-2,4-diyl)bis-(oxy)) dibenzaldehyde (DIPOD) (17) with solution of NaHSO3 in ethanol at room temperature and then subsequently added 2-aminothiophenol (14) in DMF under reflux conditions for 3 hours to afford targeted compound (18) in 74% yield Scheme 4 [45]. Synthesis of benzothiazole from 2-aminothiophenol and substituted benzaldehyde with some modifications is common, as found in many literature reports Scheme 4 [46,47]. Scheme 4: Synthesis of 4, 6-bis (4-[benzo[d]thiazole-2-yl) phenoxy)-N-N-diethyl-1, 3, 5-triazin-2-amine A more similar approach has been employed for the synthesis of benzothiazole (20) from aryl aldehyde (19) and 2-aminothiophenol (14). This approach involves the reaction of the 2-aminothiaphenol (14) with 2-hydroxybenzaldehyde (19) in the presence of 30% H2O2 and cerium 5 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 ammonium nitrate (NH4CeNO2) in acetonitrile at 50°C Scheme 5 [48,49]. Beside this, 2-substituted benzothiazoles (20) have also been synthesized from substituted aldehyde and 2-aminothiophenol in presence of various catalysts and reaction conditions such as montmorillonite, SiO2/graphite, under microwave and p-TsOH [50], diethylbromophosphonate/t-butyl hypochlorite; acetonitrile [51], H2O2/HCl in ethanol [52], AcOH/air; microwave or thermal heating [53] and Baker’s yeast, dichloromethane [54]. Scheme 5: Synthesis of 2-(Benzo[d]thiazole-2-yl) phenol Synthesis of benzothiazoles from 2-aminothiophenol and different carboxylic acids (2.2.2) You, et al., (2009) reported a perculiar method for the synthesis of naphthyridine derivatives of benzothiazole (24). In this method, 2aminothiophenol (14) undergoes cyclization on treatment with naphthyridine-3-carboxylic acid (21) in presence of polyphosphoric acid (PPA) at 170– 250°C and affords compound (22) in moderate yield. Consequently, intermediate (22) was nitrated to give intermediate, which is followed by reduction of compound (23) with Pd/C affording the final product (24) in 40–73% yield Scheme 6 [55]. Scheme 6: Synthesis of naphthyridine derivatives of benzothiazole Marques, et al., (2013) reported the coupling of 2-aminothiophenol (14) with amino acid (or ester) (25) to give access to 2substituted benzothiazoles (26). In this reaction, 2-aminothiophenol (14) was reacted with amino acid (or ester) (25) such as glycine ethyl ester and D-valine to give corresponding benzothiazole (27), in the presence of dehydrating agent such as PPA at 220°C within 4h Scheme 7 [56]. It has also been observed that benzothiazoles are produced in a high yield when ethyl ester of amino acid is used as starting material instead of amino acid. Scheme 7: Synthesis of benzothiazole from 2-aminothiophenol and amino acids 6 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 A convenient single step method for the synthesis of 2aryl benzothiazoles (29) has been reported by utilizing substituted amino benzoic acid (27) and substituted 2-aminothiophenol (29) in the presence of PPA at higher temperatures [57,58]. Simultaneously, 4-nitrobenzoic acid (30) was utilized for synthesis of benzothiazole (29), and this was achieved by subsequent reduction of the compound (30) using Fe/NH4Cl to afford compound (29) in 50-60% yield Scheme 8. It was also observed that electron withdrawing groups on the benzoic acid counterpart gave high yields of the product. Scheme 8: Synthesis of 2-(4-nitrophenyl) Benzo[d]thiazole derivatives Synthesis of benzothiazole from 2-aminothiophenol and alcohols (2.2.3) There are few reports in literature where alcohols have been used as reactants in the starting material. Rangappa, et al., (2011) reported the one-pot tandem approach for synthesis of benzothiazole (32) in which excellent yields, and was gotten using different of alcohols (31) and 2aminothiophenol (14) without any oxidant. This process includes oxidation of alcohols to aldehydes followed by cyclization with (14) and finally propylphosphonic anhydride (T3P) mediated dehydrogenation under mild reaction conditions (0–25°C). It has also be observed that the reaction of (14) with variety of aromatic, aliphatic and heterocyclic substituents reacts well under these optimized reaction conditions and provides access to high yield of the product Scheme 9 [59]. Scheme 9: Synthesis of Substituted 2-phenylbenzothiazole derivatives Suzuki-Miyaura coupling reaction (2.3) Heo, et al., (2006) reported that microwave promoted Suzuki-Miyaura coupling of 2,6-dichlorobenzothiazole(33) with arylboronic acid. This reaction was promoted efficiently by heating the two reactant in a microwave, to produce 6-chloro-2-phenylbenzo[d]thiazole in a highly regioselective manner (34) which then serve as the reactant for preparing 4-(2-phenylbenzo[b]thiophene-6-yl) morphine (35) Scheme 10 [34]. Scheme 10: Suzuki-Miyaura coupling reactions of 2,6-dichlorobenzothiazole with arylboronic acid 7 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Synthesis of benzothiazole derivatives from hydrazine (2.4) Latrofal, et al., (1996) reported the synthesis of 1, 3, 4-triazolo benzothiazole (37) from 2-hydrazinylbenzothiazole (36), which was obtained by the hydrazinolysis of benzothiazole-2-thiol (2), and mixture of trimethyl orthoformate and silica gel in xylene Scheme 11 [60]. Scheme 11: Synthesis of 1, 3, 4-triazolo benzothiazole Chemical Synthesis of Benzothiazole Derivatives (2.5) Arun, et al., (2010), reported the synthesis of N-(4, 5-dihydro-1H-imidazol-2-yl)-6-substituted-1,3-benzothiazol-2-amines (42a-c) and N-(1 Hbenzimidazol-2-yl)-6-substituted-1,3-benzothiazol-2-amines 43(a-c). This was achieved by preparing 6-substituted-2 aminobenzothiazole (40) through condensation of p-substituted aniline (38) with ammonium thiocyanate (49) in the presence of bromine as a catalyst. This reaction was followed by, addition of an aqueous solution of sodium hydroxide, Carbon disulphide and methyl iodide to a well stirred ice solution of (40) in dimethyl formamide, after an interval of 30 minutes, and then stirred continually for 4 hours. The mixture was poured in ice cold water and the resulting solid N-(benzothiazole-2-yl)-1, 3-bis (methylthio) propan-2-imine (41) was washed with water and recrystallized from aqueous ethanol. Ethylene diamine in dimethyl formamide and O-phenylene diamine in dimethyl formamide were then added to the resulting solid (41) and stirred at room temperature. The reaction mixture was reflux for 8 hours and then poured on crushed ice to get the targeted products 42(a-c) and 43(a-c) respectively Scheme 12 [61] Table 1. Scheme 12: Synthesis of N-(4, 5-dihydro-1H-imidazol-2-yl)-6-substituted-1, 3-benzothiazol-2-amines (42a-c) and N-(1 H-benzimidazol-2-yl)- 6-substituted-1, 3-benzothiazol-2-amines Table 1: Physical properties of compound (41a-c, 42a-c and 43a-c) Compounds R Molecular Formula Melting point °C 41a Cl C10H9ClN2S3 180-184 41b OCH3 C11H12N2OS3 159-161 41c NO2 C10H9N3O2S3 216-219 42a Cl C10H9ClN4S 230-234 42b OCH3 C11H12N2OS 196-199 42c NO2 C10H9N5O2S 216-218 43a Cl C14H9ClN4S 250-255 43b OCH3 C15H12N4OS 150-153 43c NO2 C14H9N5O2S 272-275 Samuel, et al., (2021) reported the synthesis of benzothiazole derivatives of sulphonamide 49(a-b). In this synthetic procedure, a solution of 8 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 diphenylamine (44) and ammonium thiocynate (39) in methanol was stirred at room temperature until the salt dissolved and become light brown in colour. On completion of the reaction which was monitored with thin layer chromatography, H2SO4 was added until the pH of the solution was 2. The orange colour precipitate obtained was filtered with suction pressure and crystallized with water to yield the product N-(biphenyl-4-yl) thiourea (45). A freshly prepared solution of bromine gas, chloroform at the temperature of 0°C to -5°C was then added to well cooled solution of 45 in chloroform to obtain a solution of 2-amino-6-phenylbenzothiazole (46). After evaporation of the solvent, 46 was washed with water and recrystallized to obtain cream colour crystal with mp 158°C and yield 64%. A solution of (47) in chloroform was added to a well stirred solution of benzosulphonyl chloride (47) in chloroform and para-toulenesulphonyl chloride (48) in chlorofom separately. The reaction mixtures were then reflux for 30 minutes. The chloroform was removed by evaporation and the residues were treated with dilute hydrochloric acid. The reaction mixtures were boiled at 45°C, decolourised with activated charcoal and filtered and a hot NaHCO3 was then added to the filtrate and stirred. The complete reactions were ascertained by litmus paper which showed no color change. The crude white products 49(a-b) were filtered upon cooling and washed with methanol and recrystallize with 1:1 chloroform/ methanol mixture Scheme 13 [62]. Scheme 13: Synthesis of benzothiazole derivatives of sulphonamide Shafi, et al., (2012) reported the synthesis of 2-mercaptobenzothiazole and 1, 2, 3-triazole based bis-heterocyclic compounds. This was achieved by reacting benzothiazole-2-thiol (2) with propargyl bromide (50) in dioxane in the presence of triethylamine to obtained compound (51) which was then treated with aromatic azides (52) using click chemistry, to afforded final product 53(a-d) Scheme 14 [63]. Scheme 14: Synthesis of 1, 2, 3-triazole based bis-heterocyclic compounds Vrushali et al., (2015) reported the synthesis of 2-amino-6-methoxy benzothiazole derivative. In this synthetic procedure, 6-methoxy-1,3benzothiazol-2-amine (54) in dry acetone was dissolved and potassium carbonate was added, the reaction mixture was irradiated for 120 seconds and then ethyl chloroacetate was added and the reaction mixture was stirred and irradiated for another 180 seconds, the reaction mass was then neutralized by using glacial acetic acid and then extraction was done by using diethyl ether. The completion of the reaction was monitored by thin 9 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 layer chromatography and the compound ethyl [(6-methoxy-1,3-benzothiazol-2-yl)amino]acetate (55) was obtained. Compound (55) was then dissolved in ethanol treated with mixture of hydrazine hydrate and hydrochloride solution and reflux for 6 hours. The reaction was cooled, poured into ice water, and a solid product 2-[(6-methoxy-1,3-benzothiazol-2-yl)amino]acetohydrazide (56) was obtained, which is then filtered, dried, and recrystallized from ethanol Scheme 15 [64]. Scheme 15: Synthesis of hydrazino benzothiazole David, et al., (2018) reported the synthesis of benzothiazole derivatives bearing carboxamide and sulphonamide functionalities. In this synthetic procedure, sodium carbonate was added to a solution of amino acids 58(a-h) in water with continuous stirring until all the solutes dissolved. The solution was cooled to -5°C and the appropriate benzenesulphony chloride 57(a-c) was added in four portions over a period of 1h. The slurry was further stirred at room temperature for 4 hours. The progress of the reaction was monitored using thin layerchromatograohy plate. Upon completion, the mixture was acidified using aqueous hydrochloric acid to pH of 2. The crystals was then filtered via suction and washed with pH 2.2 buffer. The pure products 59(a-l) were dried over self-indicating fused silica gel in a desiccator. Appropriate benzenesulphonamides 59(a-f) was dissolved in sodium hydroxide in a round bottom flask; benzoyl chloride (60) was then added to the solution and stirred at room temperature. The reaction progress was monitored by thin layer chromatography to the disappearance of the benzenesulphonamide spot. Upon completion, the solution was transferred into a beaker containing crushed ice and then acidified to pH 3 with concentrated hydrochloric acid. The solid was collected via suction filtration and transferred into a beaker containing tetrachloromethane (CCl4) and covered with watch glass and boiled for 10 minutes. The mixture was allowed to cool slightly and then filtered. The products 61(a-f) obtained were washed with CCl4 and dried over fused self-indicating silica gel in a desiccators. To a suspension of the substituted benzenesulphonamide 61(a-f) 62 (g-i) in dry toluene equipped with Dean-Stark apparatus for azeotropic removal of water, was added 2-amino-benzothiazole (2) and boric acid at room temperature and then refluxed for 6 hours. On completion (as monitored by thin layer chromatography), the amide products were precipitated out from the reaction mixture by adding n-hexane. The carboxamides 62(a-l) were obtained via suction filtration, washed with n-hexane and dried over fused silica gel or concentrated using rotary evaporator and dried over vacuum in the case of oily products Scheme 16 [65]. 16 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Scheme 25: Synthesis of the N-(5-chlorobenzothiazol-2-yl)-2-(substituted amino) acetamide derivatives Table 5: Physicochemical properties of the synthesized compound (102a-j) Compound -NR1R2 Yield (%) Melting point (°C) 102a Dimethylamino 80 196-199 102b Diethylamino 73 190-192 102c Diethanolamino 85 201-202 102d Morpholino 83 156-158 102e Piperidino 77 193-195 102f 4-fluoroanilino 67 198-200 102g 3-chloroanilino 61 193-195 102h 4-pyridino 68 190-193 102i 2-pyridino 61 167-169 102j 4-sulfanilido 69 204-206 Petal, et al., (2013) reported the synthesisof benzothiazole-2-amine derivatives 104(a-j).In this synthetic procedure, 2-aminobenzothiazole (36) in dry pyridine was refluxed with 2-(4-nitrophenyl)-5-(pyridine-3-yl)-1,3,4-oxadiazole (103) or 2-(4-chlorophenyl)-5-(pyridine-3-yl)-1,3,4-oxadiazole (103) to get the respective benzothiazole-2-amine derivatives Scheme 26 [73]. Montalvao, et al., (2016) reported the synthesis of (4-amino-5-(benzo[d]thiazole-2-yl)-arylsulfoamides 109(a-b). In this synthetic procedure, benzothiazole-2-yl-acetonitrile (105) was allowed to react with N,N-dimethylformamide dimethyl acetal (106) in ethyl alcohol at room temperature for 10 minutes to get the 2-(benzo[d]thiazole-2-yl)-3-(dimethylamino)acrylonitrile (107). This intermediate (107) was further reacted with Narylsulfonated guanidine (108) in the presence of potassium hydroxide and dioxane for 2 hours to give the synthesized compound 109(a-b) Scheme 27 [98]. 17 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Masssari, et al., (2010) reported the synthesis of ethyl-7-(4-(benzothiazole-2-yl)piperazin-1-yl)-1-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3carboxylic acid (115).This was achieved by treating ethyl-2-(2,6-dichloronicotinoyl)-3-(dimethylamino)acrylate (110) with methylamine in a diethylether/ethanol mixture to yield ethyl-2-(2,6-dichlorobenzoyl)-3-(dimethylamino)acrylate (111).This was followed by cyclization of the precursor (111) in the presence of potassium carbonate in N,N-dimethylformamide (DMF) to obtain Ethyl,7-chloro-1-methyl-4-oxo-1,4dihydroquinoline-3-carboxtlate (112) . The intermediate product (112) was then condensed with 1-(benzothiazol-2-yl)piperazine (113) in N,Ndimethylformamide (DMF) to furnish ethyl-7-(4-(benzothiazole-2-yl)piperazin-1-yl)-1-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate (114) which was then hydrolyzed in alkaline medium to afford the final product (115) Scheme 28 [75]. Jonckers, et al., (2012) reported the synthesis of 2-substituted benzothiazole derivatives bearing carboxamide functionality (122a-b). In this synthetic procedure, a commercially available epoxide (116) was treated with an excess of isobutylamaine in isopropanol to yield tertiarybutl-3hydroxy-4-(isobutylamino)-1-phenylbutan-2-yl)carbamate (117). Compound 117 was then coupled with a benzothiazole-6-carboxylic acid (118) using o-(7-azabenzotriazol-1-yl)-N,N,N’,N-tetramethyluronium hexafluorophosphate (HATU) as an activating agent in the presence of triethylamine to afford 2-substituted benzothiazole derivatives bearing carboxamide functionality119(a-b) with protected amino group, the subsequent treatment of which with trimethylsilyl chloride and sodium iodide converted the protected amino group to a reactive primary amine 120(a-b). In the final step, a triethylamine-mediated coupling of compounds 120(a-b) with 2,5-dioxopyrrolidin-1-yl thiazol-5-ylmethyl carbonate 18 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 (121) furnished final products (122a-b) in approximately 85% yield Scheme 29 [76]. Ugale, et al., (2012) reported the synthesis of quinazoline substituted benzothiazoles 123(a-c). This was achieved by heating substituted 2aminobenzothiazoles 126(a-c) and 6-bromo-2-ethyl-4H-benzo[1,3]oxazin-4-one (127) under reflux in dry pyridine to afford the product 128(a-c) Scheme 28 [77]. Medicinal Significance of Benzothiazole Scaffold (3) Benzothiazoles and their Schiff bases have shown a remarkable biological activity. The thiazole ring itself has been used as fungicide and bactericide. Some of the remarkable biological activities include: Antimicrobial activity (3.1) Microbes are causative agents for various types of disease like pneumonia, ameobiasis, typhoid, malaria, common cough and cold various infections and some severe diseases like tuberculosis, influenza, syphilis, and AIDS as well. An antimicrobial agent reduces or blocks the growth and multiplication of bacteria According to Merriam-webster Online Dictionary [78].These agents are among the most common and often injudiciously used therapeutic drugs worldwide [79], and consequently resulted in emergence of antibiotic-resistant pathogens. Antibacteria resistance is a global public health problem that has hampered the effective prevention and treatment of wide range of bacteria diseases [80-81]. Antibacteria resistance is aggravated by the misuse or overuse of antibacterial agents in people and animal [82]. Some bacteria are multidrug resistant and the major examples 19 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 are Staphylococcus aureus and Escherichia coli [82]. One of the WHO strategies for the control of antimicrobial resistance is to encourage investment in new medicine research and development [83].In accordance with this recommendation many research team are engrossed in the synthesis of new antimicrobial drug with better efficacy and lower toxicity [81-84].The most exploited derivatives are sulphonamides, thiourea and benzothiazole [85].Various approaches were made to check the role of benzothiazole moiety as antimicrobial agent. Arun, et al., (2010), reported antibacterial activity of N-(4,5-dihydro-1H-imidazol-2-yl)-6-substituted-1,3-benzothiazol-2-amines (42a-c) and N-(1 H-benzimidazol-2-yl)-6-substituted-1,3-benzothiazol-2-amines(43a-c). These compounds were tested using in-vitro assay against pathogenic Escherichia coli, Klebsiella specie, Micrococcus luteus and Staphyloccus aureus. The result was compared with some standard drugs like Novobiocin, Kanamycin and Amikacin. In the case of Escharichia coli, compound 42a, 42c and 43a exhibited higher activity at 200 µg/ml while the rest of the compounds showed moderate activity. In case the of Klebsiellia, compound 42a, 42c and 43a show higher activity than the rest of the compound. In the case of Micrococcus luteus and Staphylococcuc aureus, compound 42a, 42c and 43c showed higher activity than the rest of the compounds [61] Samuel, et al., (2021) reported the antibacterial activity of benzothiazole derivatives of sulphonamide (49a-b).The experiment was conducted using in-vitro agar well diffusion techniques .The result showed that some of the compounds inhibit the growth of both Gram negative and Gram positive bacteria organisms, only compound (45) showed inactive to the gram negative organism Escherichia coli. Compound (49b) gave the best minimum inhibition concentration amongst the synthesized compounds, while the standard ampicillin showed better activities than the synthesized compounds. The possible mechanism of the action of the synthesized compounds (49a and 49b) could be competitive inhibition of the enzyme dihydropteroate synthase that catalyze the reaction of p-aminobenzoic acid with 7,8-dihydro-6-hydroxymethylpterin-pyrophosphate to form dihydropteroic acid which is one of the step in the formation of dihydrofolic acid. The mechanism of action could be well via inhibition of carbonic anhydrase activities. Sulphonamides inhibit carbonic anhydrase and dihydropteroate synthase activities. The mechanisms of action of the thiourea (45) and benzothiazole (46) derivative could be through the inhibition of protein tyrosine kinases. The compounds had reduced activities against the Gram negative organism (E.coli) and this could be attributed to the presence of efflux pump that reduce intracellular concentration of drug in Gram negative organism [62]. Table 6: Zone of inhibition of the synthesized Compounds in (mm) Organisms Compound45 Compound46 Compound49a Compound49b Ampicillin Staphyloccus aureus 16 17 28 18 32 Escharichia coli 8 - 17 20 24 Table 7: Minimum Inhibitory Concentration of the synthesized Compounds in (µg/mL) Organisms Compound45 Compound46 Compound49a Compound49b Ampicillin Staphyloccus aureus >75.00 <75.00 50 <50.00 25 Escharichia coli >100.00 - >50.00 <50.00 12.5 Anti-inflammatory activity (3.2) Inflammation is part of the body’s immune response to stimuli. It is beneficial because it initiates healing processes. However, it is of concern because inflammation can be self-perpetuating creating more inflammation response to existing inflammation as reported by medical news [86]. Inflammatory diseases are widely prevalent world over and inflammation remains a common and poorly controlled disease which is life threatening in extreme form of allergy, autoimmune diseases, and rejection of organs transplanted [87]. Chronic inflammation has linked to a variety of diseases include cardiovascular diseases, cancer, diabetes, arthritis, Alzheimers disease, pulmonary disease, etc [87]. Non-steroidal anti-inflammatory drugs (NSAIDs) are drug class that provides analgesic, antipyretic, and anti-inflammatory effects. The most prominent members of this group are aspirin, ibuprofen, naproxen, diclofenac and indomethacin. Non-steroidal anti-inflammatory drugs (NSAIDs) exert their analgesic effect by peripheral inhibition of prostaglandin (PG) through inhibition of the cyclooxygenase (COX) enzymes, which catalyzes the conversion of arachidonic acid into the PG [88]. However, PG has a dual function, mediation of inflammation and [89] and cytoprotection against HCl [90] in the stomach and intestine. Long term use of NSAIDs for the treatment of pain and inflammation may lead to 20 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 gastrointestinal (GI) disorders and renal toxicity [91]. The work of Caughey, et al [92] and Varas-Lorenzo et al [93] has associated NSAIDs use with increased risk stroke. Various approaches have been made to check the role of benzothiazole moiety as anti-inflammatory agent. Shafi, et al., (2012) reported anti-inflammatory activities of 2-mercaptobenzothiazole and 1,2,3-triazole based bis-heterocyclic compounds(53a-d). The compounds (53a-d) were tested using biochemical cyclooxygenase (COX) activity assays and carrageenan-induced hind paw edema. The result showed that compound 53a exhibit selective COX-2 inhibition with an IC50 ratio of 0.44 of COX-2/COX-1 and displayed a better in vivo antiinflammatory activity profile compared with the industry standard, ibuprofen. Compound 53a showed increased analgesic activity compared with ibuprofen when tested using Writhing method. Importantly, the synthesized compound 53a-d displayed no gastric ulceration which has been a major downside to the clinical use of ibuprofen [63]. Arun, et al., (2010), reported the anti-inflammatory activities of the novel compound (42a-c and 43a-c). The synthesized compounds and reference drug (phenylbutanone) were examine for their anti-inflammatory activity. The pharmacological results of the synthesized compounds were reported in (Table 8). All the compounds showed anti-inflammatory activity ranging from 22.2 – 26.5% at the dose of 50 mg/kg body weight. The results obtained clearly infer that compound 42a shows the highest Anti-inflammatory activity with respect to the other compounds. Compounds 42b, 43a, and 43b showed moderate activity and compound 42c and 43c show less activity [61]. Table 8: Anti-inflammatory activity (% inhibition) of the compounds (42a-c, 43a-c and phenyl butanone). Compound % Inhibition (50 mg/kg body weight) 42a 26.5 42b 24.5 42c 22.7 43a 25.5 43b 24.7 43c 22.2 Phenyl butanone 38.9 Vrushali, et al., (2015) reported the anti-inflammatory activity of compound (55 and 56). The compound (55, 56) was tested using in-vitro assay. The study reveals that the activity of the synthesized compound (56) under test was satisfactory as compared to that of standard(Sodium Dichlofenac). That is the hydrazine derivatives were found to be potent enough to suppress haemolysis. However, the % inhibition of haemolysis in case of Sodium Dichlofenac (DFS) treated with RBC’s was high as compared to that of the % inhibition provided by the synthesis compound (56). However hydrazine compound (56) showed better result as compared to the intermediate (55) [64] Table 9: Anti-inflammatory results with % inhibition. Concentration Standard %inhibition Compound55 %inhibition Compound56 %inhibition 6.25 0.183 94.89 0.37 68.8 0.415 76.61 12.5 0.097 95.22 0.357 68.89 0.305 82.81 25 0.054 96.12 0.314 73.52 0.301 83.04 50 0.021 97.23 0.272 77.06 0.294 83.44 100 0.011 99.82 0.255 78.49 0.288 83.77 Positive control 1.186 1.186 1.186 David, et al., (2018) reported the anti-inflammatory activities of compounds (62a-l). The result shows that all compounds except 62c and 62i caused less than 50% reduction of oedema at 1 h, 2 h and 3 h (Table 10).The most pronounced anti-inflammatory activity among the compounds was 62c. The percentage reduction of reduction of 62c and 62i was higher than that of indomethacin at 1h, 2h, and 3h. The structure-activity relationship (SAR) showed that the indole ring of compound 62c was more effective in reducing oedema than that of benzene ring of 62b.Among the prolines (62g-l), compound 62i was active derivate possessing anti-inflammatory activity better than indomethacin. Substitution at four –position of the proline was shown to enhance antiinflammatory activity. The trend of the anti-inflammatory activity showed that compound 62g > 62h, 62i > 62j, and 62k > 62n.Compound 62a was the most active derivative among the aliphatic amino acid derivatives (62a, 62d-f), indicating that the higher the alkyl group β to the carboxamide, the lower the activity. The trend observed was 62a>62f>62e>62d. The presence of electron withdrawing group at the para position of the benzenesulphonamide decreased the anti-inflammatory activity as evident with compounds 62g and 62h being lower than 21 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 that of 62i and 62j. However, electron withdrawing group still showed better activity than unsubstituted ring, 62g-h > 62k-l showing that the presence of a substituent at the four-position of the benzene ring enhanced anti-inflammatory activity [65]. Table 10: Anti-inflammatory activities of compound 62a-l (Percentage inhibition of oedema formation) Compound 0.5 h 1 h 2 h 3 h 62a 32.31 7.06 7.03 12.96 62b 49.23 42.35 43.75 38.89 62c 52.31 72.01 76.36 80.09 62d 26.15 5.88 9.38 16.05 62e 27.62 17.65 14.84 1.85 62f 30.77 18.82 20.31 21.6 62g 27.62 7.06 8.59 16.05 62h 24.62 23.53 0.78 2.47 62i 41.54 64.04 73.02 78.12 62j 27.69 16.47 14.84 13.58 62k 26.15 5.88 8.28 16.67 62l 13.85 2.35 8.59 13.58 Indomethacin 56.93 63.53 64.84 63.58 Anti-tubercular Activity (3.3) Tuberculosis (TB) is a fatal contagious disease caused by infection with Mycobacterium tuberculosis but also with M. bovis and M .africanum, which can affect almost any tissue or organ of the body, the most common site of infection of the disease is the lungs as reported by medical news [94]. Various approaches were made to check the role of benzothiazole moiety as antitubercular agent. Sarkar, et al (2018) reported the antitubercular activity of compound (69a-e) against Mycobacterium tuberculosis. The compound (69a-e) was tested using in-vitro assay. Each of the compounds was dissolved in dimethylsulpoxide (DMSO). The in-vitro screening indicates that all the analogues exhibit significant anti-tubercular activity compared to that of the reference drugs isoniazid and rifampicin. These results indicate that compound 69e is more active than the other compounds, perhaps because of their low partition coefficient and consequently, the low penetration ability through the mycobacterium cell wall [66]. Table 11: The in vitro screening data of compound (69a-e) indicating their anti-tubercular activity Compound 25µg/mL (%Growth) 50µg/mL (%Growth) Minimum inhibition concentration (MIC) 69a 0% 0% 25µg/mL 69b 100% 100% 50µg/mL 69c 100% 0% 50µg/mL 69d 100% 100% 50µg/mL 69e 100% 0% 50µg/mL Isoniazid 0 0 25µg/mL Rifampicin 0 0 25µg/mL IIango and Arunkumar (2011) reported the antitubercular activity of 73(a-o) against Mycobacterium tuberculosis. The result revealed that compound 73f, 73g, 73k and 73o showed minimum inhibitory concentration (MIC) values equivalent to that of the reference standard, isoniazid. Compound 73a, 73c, 73j and 73n exhibited moderate activity, while other compounds less active [67]. 22 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Table 12: Anti-tubercular activities of compound 78(a-o) Compound R Minimum inhibitory concentration values in (µg/ml) 73a -H 2.8 73b -2-OH 50.3 73c -2-OH-3-CH3 3.7 73d -3-OH 50.3 73e -4-OH 34.2 73f -2-Cl 0.76 73g -3-Cl 0.57 73h -2 17.1 73i -3 34.8 73j -4 1.2 73k -4-N-(CH3)2 0.62 73l -3,4,5- (OCH3)3 23.4 73m -3,4,- (OCH3)2 31.4 73n -4 2.8 73o -4-Cl 0.83 Isoniazid 0.56 Anticancer Activity (3.4) Nuray, et al., (2017) reported anticancer activities of compound (77a-b). Different concentration (5, 25, 50, 75 and 100 µM ) of these compounds were used to treated PANC1 cells for 48 hours and the cytotoxicity effects of these compounds (77a and 77b) on PANC – 1 human pancreatic cancer cells was determined by the MTT assay. PANC – 1 cell were also treated with increasing concentrations of the synthesized compound (77a and 77b) to determine whether the compounds induced apoptosis. The study showed that the synthesized compound (77a and 77b) have antiproliferative effects against PANC -1 cell and reduced cell viability. These compounds (77a and 77b) also induced apoptosis of pancreatic cells and at the same time reduced the activity of SOD and GPx and reduced TAC [68]. Shi, et al., (2012) reported the anticancer activity of compounds (83a-c). These compounds (83a-c) were evaluated against various cancer cell lines. The result shows that compound 83b demonstrated promising activity against SKRB-3 human breast cancer cells (IC50 = 1.2 nM), SW620 colon cancer cells (IC50 = 4.3 nM ), A549 (IC50 = 44 nM) and HepG2 hepatic carcinoma cells (IC50 = 48 nM) as well induced apoptosis in HepG2 cancer cells [69]. AntiDiabetic Activity (3.5) Diabetes mellitus is an endocrinological and metabolic disorder with an increasing global prevalence and incidence. High blood glucose levels are symptomatic of diabetes mellitus as a consequence of inadequate pancreatic insulin or poor insulin-directed mobilization of glucose by target cells [95]. Sunil, et al., (2017) evaluated the antidiabetic activity of compound (91a-l). The result revealed that compound 91d at 350 mg/kg exerted maximum glucose lowering effects whereas 91c showed minimum glucose lowering effects [70]. Table 13: Antidiabetic activity of compound 91(a-l) Treatment (350mg/kg b.wp.o) % reduction in blood glucose 0th day 7th day 14thday 21st day 0 Normal control 105.09±1.2 102±0.3 102±0.9 100±1.2 0 Diabetic positive control 274±1.3 274±1.6 271±1.4 270±1.9 0 Glibenclamide 10 mg/kg 278±2.1 219±.4 168±1.8 95±1.7 65.82% 23 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 91a 274±1.4 243±2.8 206±1.3 158±2.3 42.33% 91b 271±2.7 235±3.1 191±0.8 144±3.3 46.86% 91c 270±1.9 246±2.7 199±1.9 161±1.5 40.37% 91d 279±3.6 274±1.5 242±2.5 102±1.8 63.44% 91e 281±2.8 238±2.9 192±1.3 149±4.1 46.97% 91f 272±1.7 254±3.2 205±1.6 159±2.9 41.54% 91g 283±1.3 230±2.5 174±1.4 110±3.1 61.13% 91h 281±4.2 235±2.7 179±1.5 114±2.6 59.43% 91i 276±3.4 250±2.2 210±0.5 165±3.2 40.21% 91j 273±1.6 240±2.6 192±2.2 136±2.4 50.18% 91k 269±2.8 244±2.3 199±1.9 146±2.1 45.72% 91l 274±1.5 242±2.5 186±1.1 123±1.8 55.10% Thube, et al., (2021) reported the antidiabetic activity of compound (97a-j).All the synthesized derivatives were screened for their antidiabetic activity using alloxan induced method. Estimation of glucose, cholesterol and triglyceride levels were carried out, and it was found that compound 97d exhibited significant antidabetic activity. Compounds 97f, 97b, and 97a possess a moderate antidiabetic activity [71]. Table 14: Effect of compound (97a-j) on Blood glucose level data Blood glucose level mg/dl (Mean±SEM) Drug 0 day 3days 6days 9day 12day Control 107.7±2.1 108.5±1.8 107.5±2.9 108.6±2.1 108.8±1.3 Diabetic Control 363.0±2.5 361.2±2.8 361.7±2.4** 361.3±2.3** 360.1±1.4 Standard 361.1±3.9 215.7±2.4** 151.1±3.2** 122.3±4.3** 101.2±2.2** 97a 357.0±2.6 235.2±3.2** 155.3±4.9** 132.4±4.7** 119.3±3.6** 97b 354.7±2.8 230.2±2.5** 154.7±3.8** 128.1±2.5** 115.4±2.1** 97c 353.0±2.2 277.4±3.9** 204.3±4.3** 160.6±2.4** 135.3±3.6** 97d 363.3±3.5 225.2±1.7** 150.4±3.5** 119.9±2.1** 102.8±1.8** 97e 382.8±4.4 272.1±2.6** 208.3±5.3** 170.5±4.1** 142.7±4.3** 97f 366.8±2.3 220.2±2.9** 152.8±3.2** 126.3±3.1** 110.5±2.3** 97g 368.8±3.2 240.3±2.1** 157.5±2.1** 139.5±2.1** 121.3±3.4** 97h 349.7±2.5 284.3±5.1** 210.1±3.3** 180.6±2.9** 145.2±4.5** 97i 350.7±4.9 275.5±4.9** 236.8±4.3** 190.8±3.7** 152.8±5.1** 97j 357.7±4.5 274.3±3.8** 239.6±5.3** 198.6±4.3** 155.0±6.9** Table 15: Effect of compound (97a-j) on Blood Cholesterol level data Cholesterol level mg/dl (Mean±SEM) Drug 0 day 6 day 12 day Control 139.3±6.1 138.4±5.3 139.5±6.7 24 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 Diabetic Control 346.3±6.1 347.3±5.4 346.4±5.9 Standard 348.5±2.1 189.4±5.1** 131.3±2.5** 97a 346.4±3.3 198.3±2.9** 134.5±2.5** 97b 342.±5.5 193.5±3.3** 133.4±3.1** 97c 341.8±6.8 262.2±4.9** 156.6±2.4** 97d 349.9±5.5 190.8±1.6** 132.6±3.9** 97e 351.6±3.8 131.4±3.2** 139.7±2.5** 97f 349.5±1.0 192.4±4.3** 131.6±5.3** 97g 348.4±4.5 216.5±1.1** 160.8±2.5** 97h 352.3±3.3 201.9±2.5** 162.2±4.4** 97i 354.3±2.3 234.1±3.5** 133.4±6.4** 97j 355.9±2.8 239.2±2.2** 131.3±2.8** Table 16: Effect of compound (97a-j) on Blood Trigyceride level data Triglyceride level mg/dl (Mean±SEM) Drug 0 day 6 day 12 day Control 120.4±9.8 121.5±8.8 120.3±9.6 Diabetic Control 251.5±7.5 252.5±6.8 251.7±7.1 Standard 249.4±8.4 188.5±7.1** 121.5±6.5** 97a 248.5±7.5 222.5±8.0** 130.2±7.5** 97b 246.9±8.4 190.4±7.2** 126.2±3.8** 97c 248.8±7.8 206.3±6.8** 115.2±7.6** 97d 246.6±8.5 191.7±6.7** 124.3±6.9** 97e 254.4±9.8 204.5±5.9** 125.4±8.6** 97f 248.4±7.0 192.9±7.5** 120.5±7.4** 97g 251.6±6.5 205.4±6.1** 147.5±3.5** 97h 253.2±5.3 212.5±7.5** 142.4±5.4** 97i 257.3±6.3 219.6±8.5** 139.6±6.4** 97j 254.4±5.8 221.8±9.0** 140.8±7.8** Mariappan, et al., (2012) reported the antidiabetic activities of N-(6-chlorobenzothiazol-2-yl)-2-(substituted amino) acetamide 102(a-j) .The LD50 values of these compounds 102(a-j) were also estimated to be in the range of 100-1000 mg/kg b.w, and the results revealed that all the synthesized compounds 102(a-j) exhibited anti-diabetic response at the end of ten days. It has been found that oral administration of the synthesis compounds 102c, 102d, 102e, and 102j caused a more significant reduction in blood glucose than other compounds in diabetic rats. However, the compound 102d at 100 mg/kg b.w. exerted maximum glucose lowering effects. The maximum glucose lowering effects of compound 102d was seen to be due to the presence of heterocyclic amine (morphine) [72]. Table 17: Effect of compound (102a-j) on Blood glucose level data Treatment ( 100mg/kg b.w p.o) Blood glucose level mg/dl (Mean±SEM) 0 day 5th day 10th day Diabetic Control 274.2±1.6 272.2±1.8** 270.5±1.7** Glibenclamide 20 mg/kg 272.8±1.6 213.6±1.35** 114.0±1.6** 25 Vivian Ifeoma Okonkwo, et al Der Pharma Chemica, 2023, 15(5): 1-28 102a 274.7±1.9 235.5±1.65** 139.5±1.6** 102b 273.2±1.9 232.7±2.23** 140.3±1.4** 102c 262.5±4.01 228.0±2.03** 132.0±2.7** 102d 268.5±1.70 231.3±1.72** 130.8±2.42** 102e 266.3±2.9 228.3±2.38** 136.0±2.3** 102f 267.5±3.2 230.7±2.42** 144.2±1.9** 102g 270.7±2.8 231.5±2.47** 148.2±2.3** 102h 271.7±2.6 232.2±3.0** 143.2±1.6** 102i 271.7±2.5 233.8±2.2** 135.7±2.5** 102j 262.5±4.02 227.7±2.7** 132.5±1.18** All the values were expressed as (Mean±SEM) (n=6). *p< 𝟎. 𝟎𝟓 and ** p< 𝟎. 𝟎𝟏 Antiulcer Activity (3.6) Arun, et al.,(2010) also evaluated the antiulcer activities of the novel compounds (42a-c and 43a-c). All the synthesized compounds showed good activity as compared with standard drug (ranitidine). Compounds 42a, 42c, 42a, and 42c showed good activity while compound 42b showed moderate activity in Aspirin Induced Ulcer (ASP). The synthesized compound were also tested for Ethanol Induced Ulcer, it was observed that compounds 42a, 42b and 42c showed moderate activity while compounds 43a, 43b, and 43c showed less activity [61]. Antiviral Activity (3.7) A virus is a very infectious agent that replicate only inside the living cells of an organism. Viruses infect all types of plants, animals, and microorganisms also, like bacteria [96]. Viral infections are considered to be one of the major threats to the health of human being. Virus infections take place due to globalization and unexpected climate changes [97]. A good number of unknown varieties of viruses maybe responsible for total infection cases. These viruses come to the picture when they show some symptoms to the host [98]. Despite the development of many molecules as antiviral, they are unable to satisfy the requirement criteria to treat the viral infection and drug resistance of current viruses. That is why it is still need of newer vaccines, diagnostic agents and antiviral molecules [99]. Considering the fact that benzothiazole moiety has versatile applications, several research findings have reported many biological activities of heterocycles containing this moiety, including antiviral effect against various species of viruses [100]. Based on the oustanding physical and chemical properties of benzothiazole moiety, many researchers have tried to synthesize various benzothiazole derivatives that show potent antiviral effects against various strain of viruses [101]. Petal, et al., (2013) reported the antiviral activity of compounds (104a-j). The compounds(104a-j) were evaluated against Human Immune Virus (HIV). The result shows that all the compound (104a-j) are active against Human Immune Virus (HIV) [73]. Montalvao, et al., (2016) reported the antiviral activity of compounds (112a-b). The compounds (104a-j) were evaluated against Herpes Simple Virus. The result reveal that compounds (112a-b) show potent antiviral activity against Herpes Simple Virus. They are also Hsp90α inhibitors with broad spectrum antiviral activity [74]. Masssari, et al., (2010) reported the antiviral activity of compound (115). The compounds (104a-j) were evaluated and the result show that the synthesized compound (115) is a potential inhibitor of the HIV-1 Tat-mediated transcription, and also exhibit antiviral activity in HIV-infected cells. Compound 115 displayed EC50=0.03 µg/mL and 0.02 µg/mL with HIV-1 and HIV-2 metal-lothionein 4 (MT-4) cells [75]. Jonckers, et al., (2012) reported the antiviral activity of the Compounds (122a-b).The Compounds (122a-b) were evaluated as pharmacokinetic enhancers of HIV protease inhibitors [76]. 3.8 Anticonvulsant Activity Ugale, et al., (2012) reported the anticonvulsant activity of compounds (125a-c). The compound (125a-c) was evaluated as anticonvulsant agents by maximal electroshock and PTZ induced seizure methods. The result revealed that compound 125a showed remarkable activity against tonic seizure, whereas compound 125c showed promising results against clonic seizure. Significantly none of the synthesized compounds (125a-c) exhibited neurotoxicity or hepato-toxicity [77]. CONCLUSION (4) From this literature review, it can be concluded that benzothiazoles and their Schiff bases have shown a wide range of medicinal value. It is a versatile nucleus in the field of medicinal chemistry. Hence this unique molecule must serve as future therapeutic leads of developing various